Recent studies have confirmed that lactylation, particularly H3K18la, plays a critical role in T-cell-mediated cancer immunotherapy by promoting immune evasion through the POM121/MYC/PD-L1 axis in non-small cell lung cancer (NSCLC). This evidence concerns the gene POM121 and non-small cell lung carcinoma.